These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15779405)

  • 1. [Screening for type 2 diabetes and impaired glucose tolerance].
    Hirata A; Tominaga M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():366-71. PubMed ID: 15779405
    [No Abstract]   [Full Text] [Related]  

  • 2. [An approach to the prevention of type 2 diabetes in industrial healthcare].
    Sumida Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():588-96. PubMed ID: 15779445
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined use of fasting plasma glucose and HbA1c (as a screening test)].
    Osawa H; Onuma H; Makino H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():390-3. PubMed ID: 15779410
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fasting plasma glucose for diagnosis of diabetes mellitus].
    Taminato T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():376-81. PubMed ID: 15779407
    [No Abstract]   [Full Text] [Related]  

  • 5. Noninvasive skin fluorescence spectroscopy for diabetes screening.
    Stirban A
    J Diabetes Sci Technol; 2013 Jul; 7(4):1001-4. PubMed ID: 23911182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylated hemoglobin levels and new diagnostic criteria.
    Raj D; Mohan V; Mohan R
    Diabetes Care; 1998 Dec; 21(12):2198-9. PubMed ID: 9839124
    [No Abstract]   [Full Text] [Related]  

  • 7. [Screening of glucose intolerance with fasting blood samples].
    Shiba T
    Nihon Rinsho; 1997 Nov; 55 Suppl():904-9. PubMed ID: 9434585
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for diabetes mellitus in the adult].
    Yoshinaga H
    Nihon Rinsho; 1990 Dec; 48 Suppl():1061-4. PubMed ID: 2086868
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive skin fluorescence spectroscopy is comparable to hemoglobin A1c and fasting plasma glucose for detection of abnormal glucose tolerance.
    Olson BP; Matter NI; Ediger MN; Hull EL; Maynard JD
    J Diabetes Sci Technol; 2013 Jul; 7(4):990-1000. PubMed ID: 23911181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward targeted prevention: risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany.
    Greiner GG; Emmert-Fees KMF; Becker J; Rathmann W; Thorand B; Peters A; Quante AS; Schwettmann L; Laxy M
    Acta Diabetol; 2020 Dec; 57(12):1481-1491. PubMed ID: 32748175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology.
    Shahim B; Gyberg V; De Bacquer D; Kotseva K; De Backer G; Schnell O; Tuomilehto J; Wood D; Rydén L
    Cardiovasc Diabetol; 2018 Jan; 17(1):21. PubMed ID: 29368616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance.
    Hellgren MI; Daka B; Jansson PA; Lindblad U
    Prim Care Diabetes; 2015 Aug; 9(4):261-6. PubMed ID: 25466159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes primary prevention program: New insights from data analysis of recruitment period.
    Gagliardino JJ; Elgart JF; Bourgeois M; Etchegoyen G; Fantuzzi G; Ré M; Ricart JP; García S; Giampieri C; González L; Suárez-Crivaro F; Kronsbein P; Angelini JM; Martínez C; Martínez J; Ricart A; Spinedi E
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28843031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glucose intolerance -- diabetes].
    Yamauchi T; Kadowaki T
    Nihon Rinsho; 2008 Sep; 66(9):1753-60. PubMed ID: 18788406
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening for NIDDM. Opportunities for detection, treatment, and prevention.
    Knowler WC
    Diabetes Care; 1994 May; 17(5):445-50. PubMed ID: 8062614
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnosis and tests for impaired glucose tolerance and borderline type].
    Ito C
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():355-60. PubMed ID: 15779403
    [No Abstract]   [Full Text] [Related]  

  • 18. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer?
    Geba D; Pearson TA
    Am J Prev Med; 2011 Jan; 40(1):101-3. PubMed ID: 21146774
    [No Abstract]   [Full Text] [Related]  

  • 20. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance.
    Mannucci E; Ognibene A; Sposato I; Brogi M; Gallori G; Bardini G; Cremasco F; Messeri G; Rotella CM
    Acta Diabetol; 2003 Dec; 40(4):181-6. PubMed ID: 14740278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.